Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
$229.71 - $259.35 $740,585 - $836,144
-3,224 Reduced 78.75%
870 $215,000
Q4 2022

Feb 01, 2023

SELL
$218.29 - $256.91 $238,809 - $281,059
-1,094 Reduced 21.09%
4,094 $1.04 Million
Q3 2022

Nov 10, 2022

BUY
$51.03 - $264.23 $111,449 - $577,078
2,184 Added 72.7%
5,188 $1.16 Million
Q2 2022

Aug 03, 2022

SELL
$234.74 - $275.42 $2.33 Million - $2.74 Million
-9,935 Reduced 76.78%
3,004 $740,000
Q1 2022

May 04, 2022

SELL
$243.64 - $270.48 $1.6 Million - $1.78 Million
-6,582 Reduced 33.72%
12,939 $3.44 Million
Q4 2021

Feb 09, 2022

SELL
$230.08 - $250.94 $1.34 Million - $1.46 Million
-5,804 Reduced 22.92%
19,521 $4.91 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $786,360 - $866,612
3,379 Added 15.4%
25,325 $6.23 Million
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $1.16 Million - $1.27 Million
4,992 Added 29.44%
21,946 $5.34 Million
Q1 2021

May 13, 2021

SELL
$232.09 - $256.88 $1.33 Million - $1.47 Million
-5,713 Reduced 25.2%
16,954 $4.12 Million
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $1.62 Million - $1.79 Million
7,287 Added 47.38%
22,667 $5.67 Million
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $1.58 Million - $2.02 Million
7,315 Added 90.7%
15,380 $3.58 Million
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $1.77 Million - $2.12 Million
8,065 New
8,065 $1.93 Million
Q1 2020

May 13, 2020

SELL
$195.69 - $279.01 $703,309 - $1 Million
-3,594 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $784,068 - $884,775
3,316 Added 1192.81%
3,594 $977,000
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $64,101 - $71,190
278 New
278 $70,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.